Amelioration of intestinal barrier dysfunction by berberine in the treatment of nonalcoholic fatty liver disease in rats
Cite This Article
Vancouver Style
Amelioration of intestinal barrier dysfunction by berberine in the treatment of nonalcoholic fatty liver disease in rats. Pharmacognosy Magazine [Internet]. 2017;13(52):677-682. https://www.ncbi.nlm.nih.gov/pubmed/29200733
.